Bioactive molecules

Cefotaxime sodium salt

  • CAS 64485-93-4
  • C16H17N5O7S2·Na
  • 478.46 g/mol

Supplied as white to light yellow crystalline powder, with a purity of 916 to 964 μg/mg.

Available formats

  • Ref. QF-Y3YMUE-1
  • Ref. QF-Y3YMUE-2
  • Ref. QF-Y3YMUE-3

Enter the units you need of each format. No published prices: we will send you a personalised quotation.

  • Harmful / irritant
  • Health hazard
  • Personalised quotation
  • Worldwide shipping
  • Expert technical support

Description

Cefotaxime sodium salt (CAS 64485-93-4), from our fine chemicals range: antibiotics and bioactive molecules. Molecular formula C₁₆H₁₇N₅O₇S₂·Na; molecular weight 478.46 g/mol.

Supplied as white to light yellow crystalline powder, with a purity of 916 to 964 μg/mg.

Store refrigerated, at 2–8 °C.

Available in 1 g, 5 g and 100 g formats.

Classified as hazardous. See the hazard and precautionary statements in the Safety tab.

Specifications

AppearanceWhite to light yellow crystalline powder
Specific rotation+58.0°~+64.0°
pH4.5–6.5
Acetone≤ 0.5 %
Loss on drying≤ 3.0 %
Assay916 to 964 μg/mg
Total impurities≤ 3.0 %
Bacterial endotoxins≤ 0.20 EU per mg
Any individual impurity≤ 1.0 %

Identification

CAS number64485-93-4
EC number264-915-9
IUPAC namesodium (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Molecular formulaC16H17N5O7S2·Na
Molecular weight478.46 g/mol
Exact mass477.0389 Da
SMILESCC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]
InChIInChI=1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1
InChIKeyAZZMGZXNTDTSME-JUZDKLSSSA-M
PubChem CID10695961
Tariff code (TARIC)2941900000

Safety and handling

Signal word (CLP): Danger

Hazard statements

H315
Causes skin irritation.
H317
May cause an allergic skin reaction.
H319
Causes serious eye irritation.
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled.
H335
May cause respiratory irritation.

Precautionary statements

P260
Do not breathe dust/fume/gas/mist/vapours/spray.
P280
Wear protective gloves/protective clothing/eye protection/face protection.
P304 + P340
IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P305 + P351 + P338
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P308 + P313
IF exposed or concerned: Get medical advice/attention.
P333 + P313
If skin irritation or rash occurs: Get medical advice/attention.
P337 + P313
If eye irritation persists: Get medical advice/attention.

Storage and transport

Storage temperature2–8 °C
Acid-base characterNeutral

Indicative information based on the CLP classification. You can request the safety data sheet together with your quotation.

Synonyms

  • Cefcil
  • Cefotax
  • cefotaxime injection
  • CEFOTAXIME SODIUM
  • HR 756
  • Pretor
  • RU 24756
  • Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate
  • Sodium cefotaxime
  • Tolycar